← All Aligos Therapeutics, INC filings

Aligos Therapeutics, INC Schedule 13D activist filings

Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.

NASDAQ
ALGS
Aligos Therapeutics, INC
SCHEDULE 13D/A: Dr. Lawrence Blatt's Stake in Aligos Therapeutics Drops Below 5% Threshold
Dr. Lawrence M. Blatt has filed an amended Schedule 13D, indicating his beneficial ownership in Aligos Therapeutics, Inc. has fallen below the 5% reporting threshold.